Novo Nordisk to lower insulin prices; EPA announces proposed drinking water limits for ‘forever chemicals’

Under mounting pressure, Novo Nordisk plans to cut U.S. list prices for several insulin products by up to 75%.

March 14, 2023 Check out STAT+

Sponsored By

Alex Hogan/STAT 'Leave the chocolate milk out of this': School cooks, parents, kids push back on USDA effort to make lunches healthier The feds are coming for your kids' chocolate milk. At least, so say the cooks, parents and kids complaining about new rules for school lunch. By Nicholas Florko STAT+ | Novo Nordisk to lower insulin prices by up to 75% amid growing pressure The move comes after Eli Lilly recently announced plans to lower list prices for its most commonly prescribed insulin products by 70%. By Ed Silverman EPA announces proposed drinking water limits for six 'forever chemicals' The EPA for the first time proposed enforceable regulations for six "forever chemicals," also called PFAS, in Americans' drinking water. By Brittany Trang Introducing the 2023 STATUS List, the definitive accounting of leaders in the life sciences The 2023 STATUS List recognizes standout individuals in health, medicine, and the life sciences whose work has advanced those fields. By STAT Staff Setting aside the thorniest issues around CRISPR babies, scientists say embryo-editing research should proceed Summit organizers urged policymakers and the public to have difficult discussions, but not at the expense of stopping progress. By Megan Molteni National Academies calls for transforming use of racial and ethnic labels in genetics research Outdated methods of grouping people in genetics research may result in poor scientific results and misguided interpretations, said report. By Usha Lee McFarling Molly Ferguson/STAT STAT+ | Amylyx's ALS drug launch starts strong. That could be trouble for the FDA The FDA could face a quandary if an ongoing and larger clinical trial shows ALS patients aren't benefiting from the drug. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser